Beclometasone Dipropionate

二丙酸倍氯米松

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBeclometasone Dipropionate
Drug Alias Name丙酸倍氯米松Beclomethasone DipropionateBeclometasonum倍氯米松双丙酸酯beclometasona +[44] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsRejection of lung transplantationCoronavirus Disease 2019 (COVID-19)Respiratory Sounds +[35] 
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1976/05/12
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesDuke UniversitySofar SpaGuangdong Sanlan Pharmaceutical Co Ltd +[5] 
Inactive CompaniesTongji UniversityHefei Licheng Pharmaceutical Co LtdGlaxosmithkline Plc +[19] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Rhinitis, AllergicBronchial Spasm +[4] 
Inactive IndicationsRejection of lung transplantationRespiratory SoundsGraft vs Host Disease +[31] 

Other Information

ATC CodeA07EA07D07AC15R01AD01 +[4] 
Related LinksWikipediaDrugBankKEGG